EATG » FDA approves changes to the Reyataz label

FDA approves changes to the Reyataz label

FDA recently approved changes to the REYATAZ (atazanavir) package insert.

The approved changes are detailed here.

Share on FacebookTweet about this on TwitterShare on Google+Pin on PinterestShare on LinkedIn
Source:
FDA
News categories: HIV treatment, EMA/FDA